Oncopharmpod
Epcoritamab
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:15:32
- More information
Informações:
Synopsis
We discuss the newly approved CD20-CD3 T-cell engager for subcutaneous (SC) administration to treat DLBLC after 2 or more lines of therapy.
